These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7000133)

  • 21. Beta-lactamase synthesis in Mycobacterium leprae.
    Prabhakaran K; Harris EB; Sanchez RM; Hastings RC
    Microbios; 1987; 49(200-201):183-8. PubMed ID: 3295489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of specific vaccine on cell-mediated immunity of armadillos against M. leprae.
    Kirchheimer WF; Sanchez RM; Shannon EJ
    Int J Lepr Other Mycobact Dis; 1978; 46(3-4):353-7. PubMed ID: 365788
    [No Abstract]   [Full Text] [Related]  

  • 24. A lost talisman: catastrophic decline in yields of leprosy bacilli from armadillos used for vaccine production.
    Storrs EE
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):67-70. PubMed ID: 10407632
    [No Abstract]   [Full Text] [Related]  

  • 25. General ideas concerning a vaccine against leprosy: a basis for discussion during the Eleventh International Leprosy Congress.
    Convit J; Ulrich M
    Int J Lepr Other Mycobact Dis; 1978; 46(1):61-3. PubMed ID: 348611
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of vaccines prepared from armadillo-derived M. leprae; results of an inter-laboratory study coordinated by the World Health Organization. Immunology of Mycobacterial Diseases (IMMYC) Steering Committee, World Health Organization.
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):48-55. PubMed ID: 7730719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing the in vitro growth of Mycobacterium leprae: effect of inoculum.
    Dhople AM
    Microbios; 1998; 94(378):103-12. PubMed ID: 9785489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 30. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients.
    Robinson P; Mahadevan PR
    J Clin Lab Immunol; 1987 Dec; 24(4):171-6. PubMed ID: 3329228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a Mycobacterium leprae specific protein antigen(s) and its possible application for the serodiagnosis of leprosy.
    Caldwell HD; Kirchheimer WF; Buchanan TM
    Int J Lepr Other Mycobact Dis; 1979 Sep; 47(3):477-83. PubMed ID: 90666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labeling of ultrathin sections.
    Rastogi N; Cadou S; Hellio R
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):278-91. PubMed ID: 2071985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro proliferation of lymphocytes from human volunteers vaccinated with armadillo-derived, killed M. leprae.
    Gill HK; Mustafa AS; Godal T
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):30-5. PubMed ID: 3549938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards a vaccine against leprosy.
    Sengupta U
    Lepr India; 1981 Jan; 53(1):88-95. PubMed ID: 7012444
    [No Abstract]   [Full Text] [Related]  

  • 37. Temperature-induced changes in viability, diphenoloxidase and permeability of Mycobacterium leprae.
    Prabhakaran K; Harris EB
    Microbios; 1985; 43(172):7-15. PubMed ID: 3929029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comments on leprosy vaccination.
    Kato L
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):693-4. PubMed ID: 2674307
    [No Abstract]   [Full Text] [Related]  

  • 39. False positive reaction of the immunohistochemistry technique using anti-BCG polyclonal antibodies to identify Mycobacterium leprae in wild nine-banded armadillos.
    Deps PD; Michalany NS; Tomimori-Yamashita J
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):327-30. PubMed ID: 15485291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research in developing countries: will leprosy vaccine be produced in Nepal?].
    Kurlberg G
    Nord Med; 1990; 105(12):338-9. PubMed ID: 2270200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.